✦ LIBER ✦

Longitudinal Analysis of Clock Drawing in Alzheimer's Disease Patients

✍ Scribed by Isabelle Rouleau; David P. Salmon; Nelson Butters

Book ID: 115591721
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 157 KB
Volume: 31
Category: Article
ISSN: 0278-2626
DOI: 10.1006/brcg.1996.0022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A comparison of clock and pentagon drawi

A comparison of clock and pentagon drawing in Alzheimer's disease

✍ Dr. John Bourke; C. Mark Castleden; Ronnie Stephen; Michael Dennis 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

Clock drawing is described as a novel, easily administered bedside measure of cognitive function. We examined from 77 ambulant elderly persons meeting NINCDS criteria for Alzheimer's disease their drawings of clock faces and overlapping pentagons. Interrater reliability for two previously published

Comparison of a clock drawing test in el

Comparison of a clock drawing test in elderly schizophrenia and Alzheimer's disease patients: a preliminary study

✍ Jeremia Heinik; Debbi Lahav; Dov Drummer; Zippi Vainer-Benaiah; Ruth Lin 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 2 views

Quantitative and qualitative analyses of

Quantitative and qualitative analyses of clock drawing in frontotemporal dementia and Alzheimer's disease

✍ BLAIR, MERVIN; KERTESZ, ANDREW; MCMONAGLE, PAUL; DAVIDSON, WILDA; BODI, NIKOLETT 📂 Article 📅 2006 🏛 Cambridge University Press 🌐 English ⚖ 387 KB

Clock drawing performance and brain morp

Clock drawing performance and brain morphology in mild cognitive impairment and Alzheimer’s disease

✍ Philipp A. Thomann; Pablo Toro; Vasco Dos Santos; Marco Essig; Johannes Schröder 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 534 KB

Alzheimer’s disease as reflected in self

Alzheimer’s disease as reflected in self-figure drawings of diagnosed patients

✍ Rachel Lev-Wiesel; Einav Hirshenzon-Segev 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 225 KB

Analysis of longitudinal data in an Alzh

Analysis of longitudinal data in an Alzheimer's disease clinical trial

✍ Ronald G. Thomas; Julie D. Berg; Mary Sano; Leon Thal 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Evidence of delayed progression is the primary mechanism for demonstrating therapeutic e cacy in clinical trials in Alzheimer's disease. In the major trials of therapeutic treatment of AD, to date, measures based on clinical judgement and cognitive performance, instead of mortality, have been used a